Bengt Jonsson

Supporting the Era of Green Pharmaceuticals in the UK

Read more

• Cell and Gene Therapies

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Read more

• Canada
• Denmark
• England
• France
• Germany
• HTA
• Oncology
• Roche
• Scotland
• Sweden
• Health Technology Assessment…
• Precision Medicine

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Read more

• HTA
• Multi-Indication Medicines
• NICE
• Novartis
• Rare and Orphan Diseases
• UK
• Combination Therapies
• Health Technology Assessment…

A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases

Read more

• Amgen
• Australia
• Canada
• Economic Evaluation
• Health Policy and Regulation
• Japan
• Netherlands
• New Zealand
• Resource Allocation
• South Korea
• UK
• Health Data and Statistics
• Healthcare Systems

Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?

Read more